Peter Wilker

Assistant Professor
Microbiology

Specialty area(s)

Immunology, influenza viruses

Current courses at UWL

Immunology, MIC 310
Immunology Laboratory, MIC 410
Fundamentals of Microbiology Laboratory, MIC 230

Teaching history

Fundamentals of Microbiology Laboratory, MIC 230
Immunology Laboratory, MIC 410
Epidemiology of Infectious Diseases, MIC 753
Introductory Virology, MIC 420

Research and publishing

1. Wilker PR, Dinis JM, Starrett G, Imai M, Hatta M, Nelson CW, et al. Selection on haemagglutinin imposes a bottleneck during mammalian transmission of reassortant H5N1 influenza viruses. Nat Commun 2013, 4: 2636.

2. Das SC, Hatta M, Wilker PR, Myc A, Hamouda T, Neumann G, et al. Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine. Vaccine 2012, 30(48):6871-6877.

3. Smith KE, Wilker PR, Reiter PL, Hedican EB, Bender JB, Hedberg CW. Antibiotic Treatment of Escherichia coli O157 Infection and the Risk of Hemolytic Uremic Syndrome, Minnesota. Pediatr Infect Dis J 2012, 31(1): 37-41.

4. Walsh KB, Teijaro JR, Wilker PR, Jatzek A, Fremgen DM, Das SC, et al. Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc Natl Acad Sci U S A 2011, 108(29): 12018-12023.

5. Kohyama M, Ise W, Edelson BT, Wilker PR, Hildner K, Mejia C, et al. Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature 2009, 457(7227): 318-321.

6. Wilker PR, Kohyama M, Sandau MM, Albring JC, Nakagawa O, Schwarz JJ, et al. Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation. Nat Immunol 2008, 9(6): 603-612.

7. Wilker PR, Sedy JR, Grigura V, Murphy TL, Murphy KM. Evidence for carbohydrate recognition and homotypic and heterotypic binding by the TIM family. Int Immunol 2007, 19(6): 763-773.

8. Bougie DW, Wilker PR, Aster RH. Patients with quinine-induced immune thrombocytopenia have both "drug-dependent" and "drug-specific" antibodies. Blood 2006, 108(3): 922-927.

9. Bougie DW, Wilker PR, Wuitschick ED, Curtis BR, Malik M, Levine S, et al. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Blood 2002, 100(6): 2071-2076.

10. Cunha PD, Lord RS, Johnson ST, Wilker PR, Aster RH, Bougie DW. Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac, a nonsteroidal anti-inflammatory drug. Transfusion 2000, 40(6): 663-668.



Education

B.A. Biology - Saint Olaf College
M.P.H. Epidemiology - University of Minnesota
Ph.D. Immunology - Washington University in Saint Louis